WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 5'1801 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 15'0901 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 8'791  8'820  8'851  8'885  8'920  9'488  9'518  8'908 
Births 93  93  94  94  95  126  143  162 
Surviving infants 92  92  93  93  94  124  140  156 
Pop. less than 5 years 467  469  468  470  470  598  732  780 
Pop. less than 15 years 1'446  1'462  1'475  1'491  1'506  1'945  2'263  2'200 
Female 15-49 years 2'009  2'020  2'032  2'046  2'061  2'322  2'312  2'252 

Number of reported cases

(Click for retrospective incidence data for Serbia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  721  11  383  37  38  4'978  37'441 
Mumps
ChartChart
  37  40  41  63  64  1'215 
Pertussis
ChartChart
  285  148  89  281  39  24  1'440  6'710 
Polio*
ChartChart
 
Rubella
ChartChart
  10  11  2'188 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  17 
Tetanus (total)**
ChartChart
  24  57  99 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Serbia)
Vaccine year result method % card seen                                                
BCG 2013  98  MICS   87  97  98  98  98  97  99* 
DTP1 2013  93  MICS   87  98 
DTP3 2013  89  MICS   87  95  93  95  93  95  95 
DTP4          88  86  88  88 
IPV1         
HepB_BD         
HepB3 2013  93  MICS   87  93  91  94  92  91 
Hib3 2013  83  MICS   87  95  92  95  94  92 
JapEnc         
MCV1          86  82  87  86  92  89 
MCV2          91  90  87  91  82 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2013  88  MICS   87  95  93  95  93  97  98 
Rota1         
RotaC         
RCV1          86  82  87  86  93 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Serbia)
BCG
ChartChart
  97  98  98  98  97  85 
DTP1
ChartChart
  98  97  98  97  98  97 
DTP3
ChartChart
  95  92  95  93  95  95 
HepB3
ChartChart
  93  91  94  92  91 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  95  92  95  94  92 
IPV1
  98  97  98 
MCV1
ChartChart
  86  82  86  86  92  89 
MCV2
ChartChart
  91  90  86  91  82  78 
PCV3
 
Pol3
  95  93  95  93  97  98 
RCV1
ChartChart
  86  82  86  86  92  89 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 25  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 92
From 80 to 89% 8
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTaPHibIPV 8, 14, 20 weeks; 18 months; Yes
HepA_Adult Yes travellers
HepB_Adult Yes special risk group
HepB_Pediatric birth; 4 weeks; 5 months; Yes
HIB Yes some chronic diseases patients
Influenza_Adult >65 years; Yes and adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric >6 months; Yes and children with chronic illness
MenACWY-135 conj Yes some chronic disease patients, travellers
MMR 12 months; 7 years; Yes
OPV 7, 14 years; Yes
Pneumo_conj Yes some chronic diseases patients
Pneumo_ps Yes some chronic diseases patients
Td 14 years; Yes
TT Yes
Typhoid Yes travellers
YF Yes travellers

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No       
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   25  25         

System performance

Total Nº districts in country number 25  25  25  25  25  25  25 
Nº districts with DTP3 coverage >=80% number 25  25  25    25  25  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100    100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   16  13  22 
% of districts with MCV1 coverage >=95% From 0 to 100% 24  20  20    64  52  88 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No    No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.